Rommel Torres

FDA’s New Initiatives Aim to Expedite Medication Approvals and Strengthen Domestic Manufacturing

At Atlantic Biologicals, staying informed about regulatory changes is part of our commitment to supporting our partners and customers across the pharmaceutical supply chain. Recent updates from the U.S. Food and Drug Administration (FDA) could signal significant improvements in how quickly certain medications reach the market — a change that may benefit patients, manufacturers, and […]

FDA’s New Initiatives Aim to Expedite Medication Approvals and Strengthen Domestic Manufacturing Read More »